chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Hypoaesthesia, Paraesthesia
Clinical narrative: Slight tingling and numbing feeling on side of face; numbing feeling on side of face; Face burning; This is a spontaneous report from a contactable consumer (who is also the Patient, reported for self).  A 38-years-old (non-pregnant) female patient received first dose of BNT162B2(Formulation: Solution for injection; Batch/Lot Number: EN6200; Expiration date: UNKNOWN), via an unspecified route of administration, administered in Arm Left on 05Mar2021 at 13:15 (at 38-years-old) as single dose for COVID-19 immunisation. Medical history included MTHFR (Methylenetetrahydrofolate reductase deficiency) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks. No known allergies. No covid prior vaccination.  On 05Mar2021 12:15 PM patient experienced Slight tingling and numbing feeling on side of face. Face burning. The patient did not receive any treatment. Since the vaccination, patient has not been tested for COVID-19. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Fever; body aches; chills; This is a spontaneous report from a contactable consumer or non-health care professional (patient). A 45-year-old male patient started to receive first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6203) via an unspecified route of administration and administered in Left arm on 05Mar2021 at 09:00 am as single dose for COVID-19 immunization. The patient experienced COVID-19 prior to vaccination and not tested post vaccination. The patient didn't receive any other vaccine in four weeks. The patient medical history and concomitant medications were not reported. On 06Mar2021, at 03:00 am the patient experienced Sore Arm, Fever, body aches and chills. The patient did not receive any treatment for events. The outcome of events was not resolved.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Swelling
Clinical narrative: rash breakout on her neck, legs, hands, and arms; swelling in her legs, feet, and ankle. Itchiness; Itchiness; This is a spontaneous report from a contactable consumer reported for daughter-in-law (Patient) via Medical Information Team. A female patient of unknown age received first dose of BNT162B2 (Pfizer-BioNTech covid-19 vaccine, Lot number: Unknown), via an unspecified route of administration, on an unspecified date as an unknown, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, patient experienced severe reaction that had a rash breakout on her neck, legs, hands, and arms and had swelling in her legs, feet, and ankle, itchiness but no fever. Patient was due to go for the second dose this week. Reporter wanted to know if patient should get the second dose and further asked about what the percentage of protection after the second dose was and does she have some protection after just one dose. The outcome of events was recovered (after lasting for a day and half).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure measurement, Body temperature, Feeling abnormal, Hypertension
Clinical narrative: Horrible feeling; Blood pressure goes high; Joint hurt; Fever/ very low temperature; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. A 77-years-old female consumer (patient) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient previously took tylenol as per her common sense and epipens (double dose) for swollen mouth and lips (due to a cleaner) two months ago. Concomitant medications were not reported. As per the description, it was reported that the patient was scared because she didn't had anyone. She was hesitated to get a vaccine. She experienced some reactions after her 2nd dose of the Pfizer vaccine. Her joint hurt and she was in a bad situation. She had a very low temperature than the normal temperature, blood pressure was high when she got upset. She was very angry that she had fever and had nobody to ask a question. She reported that no one told her about a high fever (100.4) or to go to the hospital. She said it was not worth it for her to get a fever. She reported the information on the paper was very vague and not clear, she felt horrible as she suffered and wanted to let know. She wanted to complain that the temperature of fever was not written and none of those were approved. She was asked to contact her local doctor. That was the most horrible experience for her. The patient underwent lab tests and procedures which included blood pressure measurement as high, body temperature as and 100.4. The outcome of all the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Horrible feeling; Blood pressure goes high; Joint hurt; Fever/ very low temperature; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. A 77-years-old female consumer (patient) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient previously took tylenol as per her common sense and epipens (double dose) for swollen mouth and lips (due to a cleaner) two months ago. Concomitant medications were not reported. As per the description, it was reported that the patient was scared because she didn't had anyone. She was hesitated to get a vaccine. She experienced some reactions after her 2nd dose of the Pfizer vaccine. Her joint hurt and she was in a bad situation. She had a very low temperature than the normal temperature, blood pressure was high when she got upset. She was very angry that she had fever and had nobody to ask a question. She reported that no one told her about a high fever (100.4) or to go to the hospital. She said it was not worth it for her to get a fever. She reported the information on the paper was very vague and not clear, she felt horrible as she suffered and wanted to let know. She wanted to complain that the temperature of fever was not written and none of those were approved. She was asked to contact her local doctor. That was the most horrible experience for her. The patient underwent lab tests and procedures which included blood pressure measurement as high, body temperature as and 100.4. The outcome of all the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abnormal faeces, Nausea, Vomiting
Clinical narrative: after lunch he vomitted; stool is very liquid like; felt a little sick to his stomach; feel nauseous; This is a spontaneous report from a contactable consumer reporting for a 79-years-old male patient who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number and Expiration date was unknown) via an unspecified route of administration in right arm on 04Mar2021 at 17:15 as 1 ST DOSE, single for COVID-19 immunization. The patient medical history included cholestrol, blood pressure, light asthma, stroke in 2014 and allergies with bactrum, tapes and hydrocodone. The patient previously took bactrum t and hydrocodone and experienced   drug hypersensitivity. It was reported that the patient did not take any vaccine in four weeks, he did not have covid prior vaccination and did not get tested for covid post vaccination. The concomitant medications included lansoprazole 30mg twice a day, clopidogrel 75 mg, lisinopril 20mg, metoprolol tartrate 50mg, evolocumab (Repatha)140mg injection pen, colecalciferol (Vitamin D) 1000 iu twice a day, fiber, cyanocobalamin (Vitamin B12), fluticasone furoate, vilanterol trifenatate (Breo ellipta) inhaler, fexofenadine hydrochloride (Allegra) and macrogol 3350 (Miralax) all taken for unknown indication, start date and ongoing status unknown. Approximately 1 to 2 hours after the shot on 04Mar2021, he felt a little sick to his stomach, during the night he felt bad but did ok. On the next day on 05Mar2021 he ate breakfast felt ok and after lunch he vomited and his stool was very liquid like. On an unknown date in Mar2021, he continued to feel nauseous. No fever just feels nauseous still on Saturday, after he eats he then has to vomit. Stool and vomit all have the same look. He was not keeping any food down but was drinking a lot of water. Just taking a lite diet, broth, toast, crackers, etc. Patient did not received treatment for the events. The outcome of events was recovering.  No follow-up attempts were possible; information about lot/batch number cannot be requested.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Nausea; Mild headache; Tiredness; Muscles aches; Chills; Sore arm; This is a spontaneous received report from a contactable other hcp. A 36-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6205, Pfizer NTEC), via an unspecified route of administered in Arm Right on 03Mar2021 14:00 as 2nd dose, single dose for covid-19 immunisation. Medical history included, migraine from an unknown date and unknown if ongoing. Concomitant medications included Multivitamin, vitamin D, vitamin b taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. The patient previously took first dose of BNT162B2 (Lot: EL9264) on 10Feb2020 at 01:15 PM in the right arm for COVID-19 immunisation. The patient experienced on 03Mar2021, Sore arm-9pm, 04Mar2021 Next day nausea with mild headache and tiredness 12noon muscles aches with chills-no fever, following day tiredness. The events assessed as non-serious. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Facility type vaccine: Doctor's office/urgent care. The outcome of the events was reported as recovered on unknown date. No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Nausea; Mild headache; Tiredness; Muscles aches; Chills; Sore arm; This is a spontaneous received report from a contactable other hcp. A 36-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6205, Pfizer NTEC), via an unspecified route of administered in Arm Right on 03Mar2021 14:00 as 2nd dose, single dose for covid-19 immunisation. Medical history included, migraine from an unknown date and unknown if ongoing. Concomitant medications included Multivitamin, vitamin D, vitamin b taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. The patient previously took first dose of BNT162B2 (Lot: EL9264) on 10Feb2020 at 01:15 PM in the right arm for COVID-19 immunisation. The patient experienced on 03Mar2021, Sore arm-9pm, 04Mar2021 Next day nausea with mild headache and tiredness 12noon muscles aches with chills-no fever, following day tiredness. The events assessed as non-serious. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Facility type vaccine: Doctor's office/urgent care. The outcome of the events was reported as recovered on unknown date. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: caller has the flu currently; sore throat; This is a spontaneous report from a contactable consumer (patient) by a Pfizer-sponsored program.   A 46-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 13Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and  concomitant medications were not reported. The patient experienced flu currently and sore throat on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test negative on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Lip swelling, Paraesthesia oral, Rash, SARS-CoV-2 test
Clinical narrative: Severe rash all over my body; Swelling and tingling of tongue and lips; Swelling and tingling of tongue and lips; Swelling and tingling of tongue and lips; slight heart beat increase; have a big bump on my left arm that is warm to the touch; have a big bump on my left arm that is warm to the touch; This is a spontaneous report from a contactable other health care professional reporting for herself. A 56-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202, Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 27Feb2021 13:30 as single dose for covid-19 immunization. Medical history included type 2 diabetes mellitus, essential tremor and patient reported she had too many allergies to list. The patient had COVID prior to vaccination. Concomitant medication included chromic chloride, cinnamomum spp., gymnema sylvestre, thioctic acid (DIABETES). The patient did not receive any other vaccine in four weeks. Patient tested COVID post vaccination. On 27Jan2021 13:45 the patient experienced and reported that, "severe rash all over my body, swelling and tingling of tongue and lips, slight heartbeat increase, I still have a big bump on my left arm that was warm to the touch". Therapeutic measures taken as result of adverse events: treatment included Benadryl and Motrin. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal swab test) negative on 31Jan2021. The outcome of events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Severe rash all over my body; Swelling and tingling of tongue and lips; Swelling and tingling of tongue and lips; Swelling and tingling of tongue and lips; slight heart beat increase; have a big bump on my left arm that is warm to the touch; have a big bump on my left arm that is warm to the touch; This is a spontaneous report from a contactable other health care professional reporting for herself. A 56-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202, Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 27Feb2021 13:30 as single dose for covid-19 immunization. Medical history included type 2 diabetes mellitus, essential tremor and patient reported she had too many allergies to list. The patient had COVID prior to vaccination. Concomitant medication included chromic chloride, cinnamomum spp., gymnema sylvestre, thioctic acid (DIABETES). The patient did not receive any other vaccine in four weeks. Patient tested COVID post vaccination. On 27Jan2021 13:45 the patient experienced and reported that, "severe rash all over my body, swelling and tingling of tongue and lips, slight heartbeat increase, I still have a big bump on my left arm that was warm to the touch". Therapeutic measures taken as result of adverse events: treatment included Benadryl and Motrin. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal swab test) negative on 31Jan2021. The outcome of events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder
Clinical narrative: black swirls across left eye, as if someone swirled ink across it.; This is a spontaneous report from a contactable Consumer (patient). A 67-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: was not reported) via an unspecified route of administration in arm left on 04Mar2021 15:30 as 1st dose, single for COVID-19 immunisation. Medical history included known allergies sulfa drugs, tomatoes, gluten. Concomitant medications were not reported. No covid prior vaccination and not covid tested post vaccination. On 06Mar2021, 12:00 PM the patient experienced black swirls across left eye, as if someone swirled ink across it. It just started this afternoon. There were several swirls, however, as I type this they have reduced in size. Unless it becomes worse, patient don't need to contact a doctor. No treatment was received. The clinical outcome of the event was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Chills, Cough, Myalgia
Clinical narrative: swelling in left armpit; tightness in chest and around upper rib cage; dry cough; Fever 102.3; pain at injection site; severe joint and muscle pain; chills; severe joint and muscle pain; This is a spontaneous report from a contactable consumer or other non-health care professional. A 45-year-old female consumer (non-pregnant Patient) started to receive second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN 600) via an unspecified route of administration and administered in left arm on 02Mar2021 16:15 as second dose, single dose for COVID-19 immunization. Medical history included Beta thalassemia minor. The patient concomitant medications were not reported. Historical vaccine includes first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6201) via an unspecified route of administration, administered in left arm on 13Feb2021 16:15 as 1st dose, single dose for COVID-19 immunization. The patient did not experience COVID-19 prior vaccination and not tested for Covid-19 and no known allergies. On 03Mar2021 patient experienced fever 102.3 severe joint and muscle pain, chills, swelling in left armpit, pain at injection site, tightness in chest and around upper rib cage. After 36 hours, all symptoms but chest tightness and dry cough subsided. Now at more than 48 hours post vaccine, chest tightness and dry cough remain. The patient underwent lab tests and procedures which included pyrexia: 102.3 on 03Mar2021. The patient did not receive any treatment for events, no other vaccination in other four weeks and no other medication in 2 weeks. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vaccination site pain
Clinical narrative: swelling in left armpit; tightness in chest and around upper rib cage; dry cough; Fever 102.3; pain at injection site; severe joint and muscle pain; chills; severe joint and muscle pain; This is a spontaneous report from a contactable consumer or other non-health care professional. A 45-year-old female consumer (non-pregnant Patient) started to receive second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN 600) via an unspecified route of administration and administered in left arm on 02Mar2021 16:15 as second dose, single dose for COVID-19 immunization. Medical history included Beta thalassemia minor. The patient concomitant medications were not reported. Historical vaccine includes first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6201) via an unspecified route of administration, administered in left arm on 13Feb2021 16:15 as 1st dose, single dose for COVID-19 immunization. The patient did not experience COVID-19 prior vaccination and not tested for Covid-19 and no known allergies. On 03Mar2021 patient experienced fever 102.3 severe joint and muscle pain, chills, swelling in left armpit, pain at injection site, tightness in chest and around upper rib cage. After 36 hours, all symptoms but chest tightness and dry cough subsided. Now at more than 48 hours post vaccine, chest tightness and dry cough remain. The patient underwent lab tests and procedures which included pyrexia: 102.3 on 03Mar2021. The patient did not receive any treatment for events, no other vaccination in other four weeks and no other medication in 2 weeks. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Anal incontinence, Back pain, Body temperature, Body temperature increased, Chills
Clinical narrative: Temperatures 105; chills; confusion; unsteady walking needing, great assist; Severe pain in back and neck; Severe pain in back and neck; Not eating, taking water OK; Incontinent of urine and stool; Incontinent of urine and stool; This is a spontaneous report from a contactable (patient). A 79-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number was not reported), via an unspecified route of administration, administered in left arm on 04Mar2021 at 10:00 (at the age of 79-years-old), as single dose for COVID-19 immunisation. Medical history included aortic heart valve replaced, mild COPD, edema in legs, irregular heartbeat. Patient had no known allergy. Patient not diagnosed with COVID-19 prior to vaccination. Patient was not received any other vaccine prior four weeks of vaccination. Concomitant medication(s) included MELOXICAM, LASIX and HCTZ. On 04Mar2021 at 14:00 (same day after vaccination), patient experienced temperatures 105, chills, confusion, unsteady walking needing, great assist, severe pain in back and neck, not eating, taking water OK, Incontinent of urine and stool. Patient did not receive any treatment for the events. Since vaccination patient not tested for COVID-19. The patient underwent lab tests and procedures which included Body Temperature: 105 on 04Mar2021. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Eating disorder, Gait disturbance, Neck pain, Urinary incontinence
Clinical narrative: Temperatures 105; chills; confusion; unsteady walking needing, great assist; Severe pain in back and neck; Severe pain in back and neck; Not eating, taking water OK; Incontinent of urine and stool; Incontinent of urine and stool; This is a spontaneous report from a contactable (patient). A 79-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number was not reported), via an unspecified route of administration, administered in left arm on 04Mar2021 at 10:00 (at the age of 79-years-old), as single dose for COVID-19 immunisation. Medical history included aortic heart valve replaced, mild COPD, edema in legs, irregular heartbeat. Patient had no known allergy. Patient not diagnosed with COVID-19 prior to vaccination. Patient was not received any other vaccine prior four weeks of vaccination. Concomitant medication(s) included MELOXICAM, LASIX and HCTZ. On 04Mar2021 at 14:00 (same day after vaccination), patient experienced temperatures 105, chills, confusion, unsteady walking needing, great assist, severe pain in back and neck, not eating, taking water OK, Incontinent of urine and stool. Patient did not receive any treatment for the events. Since vaccination patient not tested for COVID-19. The patient underwent lab tests and procedures which included Body Temperature: 105 on 04Mar2021. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Gait disturbance, Insomnia
Clinical narrative: Woke up with excruciating pain in right hip; Could barely walk; Was tired the next morning on the 12th; severe chills of her life with her entire body shaking; Hard to get warm and sleep; This is a spontaneous report from a contactable consumer (patient). An 80-year-old non-pregnant female patient received second dose of BNT162B2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: EL 9266, Expiration date: Unknown), via an unknown route in the left arm on 11Feb2021 at 15:00 as a single dose for covid-19 immunization. Medical history included known allergies: sulfur as a preservative and in any form and her blood does clot, but more slowly. Concomitant medications included Atenolol, 25 mg 2 times a day. Historical vaccine included first dose of BNT162B2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: EL 8982), via an unspecified route in the left arm on 20Jan2021 at 16:00 as a single dose for covid-19 immunization. Patient did not receive any other vaccine in four weeks. On 11Feb2021 night and 12Feb2021 at 15:00, patient experienced most severe chills of her life with her entire body shaking, hard to get warm and sleep. She was tired the next morning (12Feb2021). She took a nap in the afternoon and woke up with excruciating pain in right hip and would barely walk (12Feb2021 at 15:00). Her severe pain continued. Adverse events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Patient received unknown treatment for the events. The patient underwent lab test and procedure which included sonogram on 18Feb2021. The clinical outcome of the severe chills with her entire body shaking, hard to get warm and sleep, tired was recovered, patient received a sonogram on 18Feb2021 and the next day the pain (excruciating pain in right hip) suddenly disappeared (19Feb2021) and outcome of event barely walk was also recovered (19Feb2021).  No follow-up attempts needed. No further information expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: Woke up with excruciating pain in right hip; Could barely walk; Was tired the next morning on the 12th; severe chills of her life with her entire body shaking; Hard to get warm and sleep; This is a spontaneous report from a contactable consumer (patient). An 80-year-old non-pregnant female patient received second dose of BNT162B2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: EL 9266, Expiration date: Unknown), via an unknown route in the left arm on 11Feb2021 at 15:00 as a single dose for covid-19 immunization. Medical history included known allergies: sulfur as a preservative and in any form and her blood does clot, but more slowly. Concomitant medications included Atenolol, 25 mg 2 times a day. Historical vaccine included first dose of BNT162B2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: EL 8982), via an unspecified route in the left arm on 20Jan2021 at 16:00 as a single dose for covid-19 immunization. Patient did not receive any other vaccine in four weeks. On 11Feb2021 night and 12Feb2021 at 15:00, patient experienced most severe chills of her life with her entire body shaking, hard to get warm and sleep. She was tired the next morning (12Feb2021). She took a nap in the afternoon and woke up with excruciating pain in right hip and would barely walk (12Feb2021 at 15:00). Her severe pain continued. Adverse events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Patient received unknown treatment for the events. The patient underwent lab test and procedure which included sonogram on 18Feb2021. The clinical outcome of the severe chills with her entire body shaking, hard to get warm and sleep, tired was recovered, patient received a sonogram on 18Feb2021 and the next day the pain (excruciating pain in right hip) suddenly disappeared (19Feb2021) and outcome of event barely walk was also recovered (19Feb2021).  No follow-up attempts needed. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: I have had a "chemical" taste and smell since my second vaccine even though I had Covid in Oct2020 and did not have taste or smell alterations; This is a spontaneous report received from a contactable other Health Care Professional. A 59-years-old non pregnancy female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EK 923, Expiration date: Unknown) via an unspecified route of administration, in Arm Left on 07Jan2021 (at the age of 59-years-old) as single dose for Covid-19 immunisation. The patient medical history included Covid-19 on Oct2020. The patient had no known allergies. Patient had a historical vaccine of bnt162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EK 5730, Expiration date: Unknown), via an unspecified route of administration, in Arm right on 16Dec2020 (at the age of 59-years-old) as single dose for Covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received the medications within 2 weeks included calcium; linum usitatissimum seed oil; curcuma longa; cyanocobalamin; colecalciferol taken all for an unspecified indication, start and stop date were not reported. The patient was diagnosed for COVID, prior vaccination. The patient was not tested for COVID, post vaccination. The patient had experienced a "chemical" taste and smell since her second vaccine even though she had covid in Oct2020 and did not have taste or smell alterations on 08Jan2021. The patient did not received treatment for the events. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Lymphadenopathy
Clinical narrative: Lymph nodes under both arms have been swollen for 4 weeks; The patient received first dose and second dose on same day; The patient received first dose and second dose on same day; This is a spontaneous report from a contactable consumer. A 76-years-old non pregnant female consumer (patient) reported for herself that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN1283) via an unspecified route of administration on 03Feb2021 at 10:00 in left arm as a single dose and second dose (Batch/Lot Number: EN5318) via an unspecified route of administration on 03Feb2021 at 12:00 in right arm as a single dose for covid-19 immunization. Medical history included known allergies and concomitant medications were not reported. The patient did not received any other vaccine in four weeks or other medication in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. On 10Feb2021 at 12:00, the patient reported he had lymph nodes under both arms and they were swollen for four weeks.The patient received first dose and second dose on same day. The patient did not received any treatment. The outcome of the event lymphadenopathy was not recovered and for other events was unknown.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: minor soreness; This is a spontaneous report from a contactable consumer. This consumer reported for an elderly patient over 65 years old (who is reporter's sister) that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection) via an unspecified route of administration on an unknown date as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On the first day of vaccination, on unknown date she had minor soreness. She stated she was blessed to get it as she did not get any/not even 1 side effect (extremely happy) no headache. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Illness, Joint swelling, Malaise
Clinical narrative: 4 days after first shot i became sick; swelling in wrist; swelling in knees; nausea; chills; headache; feeling unwell; This is a spontaneous report from a contactable consumer (who is also the patient, reported for self).   A 67-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VAC-CINE; Formulation: solution for injection; Batch/Lot Number: EL9269; Expiration date: UNKNOWN), via an unspecified route of administration in Left arm on 13Feb2021 as single dose for COVID-19 immunisation. The patient also received second dose via unspecified route of administration in left arm on 06Mar2021 (Batch/Lot Number: EN6203). The patient medical history was not reported. Patient had No known allergies. The patient received other medications (unspecified) in two weeks. The patient received no other vaccine in four weeks. The patient was not tested for COVID prior to vaccination.   It was reported that 4 days after first shot patient became sick swelling in wrist knees nausea chills headache feeling unwell on 17Feb2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient did not received treatment for the adverse events. The patient was tested for COVID post vaccination. The patient underwent lab tests and procedures which included Qualitative PCR (Nasal Swab) sars-cov-2 test: unknown result on 26Feb2021. Outcome of all the events, sick swelling in wrist knees nausea chills headache feeling unwell was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test
Clinical narrative: 4 days after first shot i became sick; swelling in wrist; swelling in knees; nausea; chills; headache; feeling unwell; This is a spontaneous report from a contactable consumer (who is also the patient, reported for self).   A 67-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VAC-CINE; Formulation: solution for injection; Batch/Lot Number: EL9269; Expiration date: UNKNOWN), via an unspecified route of administration in Left arm on 13Feb2021 as single dose for COVID-19 immunisation. The patient also received second dose via unspecified route of administration in left arm on 06Mar2021 (Batch/Lot Number: EN6203). The patient medical history was not reported. Patient had No known allergies. The patient received other medications (unspecified) in two weeks. The patient received no other vaccine in four weeks. The patient was not tested for COVID prior to vaccination.   It was reported that 4 days after first shot patient became sick swelling in wrist knees nausea chills headache feeling unwell on 17Feb2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient did not received treatment for the adverse events. The patient was tested for COVID post vaccination. The patient underwent lab tests and procedures which included Qualitative PCR (Nasal Swab) sars-cov-2 test: unknown result on 26Feb2021. Outcome of all the events, sick swelling in wrist knees nausea chills headache feeling unwell was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: 3/6/2021 noticed loss of taste; This is a spontaneous received report from a contactable consumer reporting for himself. A 75-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot# and expiration date were not reported), via an unspecified route of administered in Arm Left on 03Mar2021 10:30 as single dose for covid-19 immunization. Medical history included diabetes, diabetes insipidus, prostate cancer, chronic kidney disease, and Some selfish allergy from an unknown date and unknown if ongoing. Concomitant medications included glipizide, and desmopressin acetate (DDAVP) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, did not tested for COVID-19. Facility type Vaccine: Hospital. The patient previously took first dose of BNT162B2 (Lot: unknown) on 16Feb2020 at 10:45 AM in the Left arm for COVID-19 immunization. On 06Mar2021 11:15, the patient noticed loss of taste. The events assessed as non-serious. No treatment was received for the events. The outcome of the events was reported as not resolved.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Pain at injection site; Tiredness; This is a spontaneous report from a non-contactable consumer (Patient). A 34-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 09:45 as 1ST DOSE, SINGLE for covid-19 immunization. Medical history included obesity, Pet Allergy, outdoor allergy, Known allergies: Carrots. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not received any treatment and was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19 as well. Concomitant medication included Montelukast, birth control taken for an unspecified indication, start and stop date were not reported. On 05Mar2021 14:30 the patient experienced pain at injection site, tiredness. No treatment received for the events. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: on and off for a week after my vaccination my arms would turn red and become very itchy; on and off for a week after my vaccination my arms would turn red and become very itchy; This is a spontaneous report from a contactable consumer (patient). A 20-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at 20-years age)  as UNKNOWN, SINGLE DOSE  for covid-19 immunisation. Medical history included pulmonary valve stenosis, mitral valve incompetence, aortic valve incompetence, eczema mild eczema (almost never flares up on my forearms  I believe these recent rashes were caused by the vaccine) from an unknown date and unknown if ongoing. Concomitant medication(s) included fluoxetine hydrochloride (PROZAC) for unspecified indication; desogestrel, ethinylestradiol (APRI) taken for contraception (birth control), within 2 weeks of vaccination. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. On an unspecified date, the patient experienced on and off for a week after my vaccination my arms would turn red and become very itchy. It was not constant and it was mitigated by soothing moisturizer. No treatment received for the events. Outcome of events was resolved on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: had swollen/tender lymph nodes in left armpit; This is a spontaneous report from a contactable consumer (Patient). A 71-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN9581), via an unspecified route of administration, administered in left arm on 25Feb2021 at 09:45 (at the age of 71-years-old), single dose for COVID-19 immunisation. The patient medical history included allergies to Amoxicillin and Bactrim. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL3249), via an unspecified route of administration, administered in left arm on 04Feb2021 at 9:45 for COVID-19 immunization. There were no concomitant medications. Patient received no other vaccine in four weeks and no other medications in two weeks prior vaccination. Patient was not diagnosed with prior vaccination. On 27Feb2021, the patient had swollen/tender lymph nodes in left armpit. Patient did not receive any treatment for event. Patient was not tested for COVID-19 post vaccination. The outcome of event was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Nausea, Peripheral swelling, Pyrexia
Clinical narrative: Second dose swelling and redness from from shoulder to elbow and exhaustion for two days after.; Seconddose swelling and redness from shoulder to elbow and exhaustion fortwo days after; Second dose swelling and redness from from shoulder to elbow and exhaustion for twodays after; Sixth and seventh days,exhaustion is back with fever, nausea,and swelling getting bigger; Sixth and seventh days,exhaustion is back with fever, nausea,and swelling getting bigger; This is a spontaneous report from a contactable consumer. This female consumer reported for herself that a 71-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6200) via an unspecified route of administration, in left arm on 27Feb2021 12:00 (at the age of 71-years-old) as 2nd dose, single for covid-19 immunisation and first dose (Batch/Lot Number: EL9269) via an unspecified route of administration, in left arm on 04Feb2021 12:00 as 1st dose, single for covid-19 immunisation. Medical history included diabetes and high blood pressure. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. Concomitant medications were not reported. Other medications in two weeks reported. No known allergies reported. The patient did not receive any vaccines within four weeks prior to the vaccination. No reaction with 1st dose. After second dose, the patient experienced swelling and redness from shoulder to elbow and exhaustion for two days after. Third, fourth, and fifth days, exhaustion gone but swelling and redness still there but area getting smaller. Sixth and seventh days, exhaustion is back with fever, nausea and swelling getting bigger. The patient did not receive any treatment for the event. Outcome of all events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Injection site pain, Muscular weakness
Clinical narrative: This is a spontaneous report from a contactable other Health Care Professional (patient). A 59-years-old male patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number: En6198, Expiration date: Unknown), via an unspecified route of administration, in Arm Left on 05Mar2021 at 13:30 (at the age of 59-year-old) as 1ST DOSE, SINGLE for Covid-19 immunization at Public Health Clinic/Administration facility. The patient medical history included thyroid disorder from an unknown date (Low thyroid numbers), migraine from an unknown date (Chronic), hypotension from an unknown date (Low blood pressure), raynaud's phenomenon from an unknown date (Raynauds syndrome). The patient had no known allergies. The patient had received concomitant medications within 2 weeks included nifedipine (NIFEDIPINE), levothyroxine (LEVOTHYROXINE), trazodone (TRAZODONE) and tamsulosin (TAMSULOSIN) were taken for an unspecified indication, from an unknow start date. The patient did not receive other vaccines within four weeks of vaccination. The patient was not diagnosed with COVID-19, prior the vaccination. The patient was not tested for COVID-19, post vaccination. On 05Mar2021 at 12:00 AM (approximately 6 hrs post vaccination), the patient felt extreme weakness, dizziness, brain fog. The patient woke up for work but had to call in sick sure to extreme weakness and dizziness along with severe pain at injection site. The patient did not receive treatment for the events. The outcome of the event was reported as recovering.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: 2 inches raised red and itchy rash on left upper arm at site of injection.; 2 inches raised red and itchy rash on left upper arm at site of injection.; 2 inches raised red and itchy rash on left upper arm at site of injection.; covid test; This is a spontaneous report from a contactable consumer (patient, reported for self).  A 72-year-old (non-pregnant) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for Injection; Batch/Lot number: 6/2021; Expiration date: UNKNOWN), via an unspecified route of administration, administered in Left arm on 25Feb2021 11:15 (at the age of 72-year-old) as single dose for COVID-19 immunization. The patient known allergies: Penicillin; other medical history included CLL (Chronic lymphocytic leukaemia), HBP (Blood pressure high), anxiety. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient concomitant medications included losartan, cefalexin monohydrate (LEXIPRON), rosuvastatin calcium (CRESTOR), etodolac (LODINE) all taken at an unspecified dose for unspecified indications from unspecified date and unknown if ongoing. The patient did not receive other vaccines prior to the COVID vaccine within 4 weeks.   The patient experienced 2 inches raised red and itchy rash on left upper arm at site of injection on 06Mar2021 20:00 (reported as 08:00 PM). The patient underwent lab tests and procedures (COVID tested post vaccination) which included nasal swab test on 04Mar2021, result: Unknown. The patient had tested for COVID-19 post vaccination. The patient did not receive any treatment for the events. Outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.